As part of a recent Power Hour, an internal speaker series, our Women in Lundbeck Lead (WILL) ERG showcased their contributions to the drug pathway journey from research to patient, illustrating the critical role they play in driving innovation and improving patient outcomes.

NEWS: Today, Lundbeck announced that an investigational drug has been granted Fast Track Designation from the US FDA. This investigational drug is currently in a Phase 3 trial for the treatment of Multiple System Atrophy (MSA). Learn more:

On this International Day of Women and Girls in Science, we are proud to support and celebrate the achievements of women in science. Learn more from just a few of the inspiring women at Lundbeck who are shaping the future of #science and #innovation. #IDWGS

During our @statbrandstudio conversation, patient advocate Shoshana Lipson shared her expert opinion on how patient-provider conversations can empower patients to take an active role in their future migraine management plan. Watch the full panel here:

NEWS: Today, Lundbeck announced results from an open-label extension study of an investigational drug in participants with Developmental and Epileptic Encephalopathies (DEEs). Learn more:

We asked experts "How do we raise the bar for severe #migraine care?" During our @statnews conversation, Dr. Amaal Starling, MD, FAHS, FAAN, shared her perspective on the importance of meaningful outcomes and illuminating needs for continued migraine research.

We were fortunate to hear from Alzheimer's experts at an immersive educational program. The engaging discussions and moving stories shared by experts, patients, and caregivers left a lasting impact as we learned more about the disease. #AdvancingBrainHealth #TransformingLives

Today, we honor the life and legacy of Dr. Martin Luther King, Jr. as we reflect on his lasting impact and commitment to equity and justice for all. At Lundbeck US, we strive each day to honor Dr. King and his teachings through our work and service in the community. #MLKDay

ICYMI: Lundbeck sponsored a @statnews conversation on “Advancing Severe Migraine Care.” Panelists from Lundbeck, academia, and patient communities unpacked the effects of severe migraine, clinical trials, and reimagining patient-provider conversations:

Join us in congratulating Shae Maughmer for being named Senior Vice President, Chief Commercial Officer. Shae is a proven leader who delivers on business goals while motivating & inspiring those around her. She instills a culture focused on the patients & communities we serve.

As we wrap up 2024, we're reflecting on a meaningful year, dedicated to advancing brain health and transforming lives. From community and advocacy partnerships to always staying true to our people-first approach, this year was one to remember. Thank you to our team and partners!

We're committed to partnering with the patient communities we serve. It’s especially meaningful when we hear from leaders in the community about the impact of engaging and supporting patients, caregivers, and advocates in our efforts to advance brain health and transform lives.

#NEWS: In collaboration with @OtsukaUS, we’re proud to share that @JAMAPsych published positive Phase 3 trial results evaluating the treatment of post-traumatic stress disorder (PTSD) in adults. Learn more:

Last year, the Lundbeck US Charitable Fund contributed over $2.5 million to charitable organizations driving meaningful change in brain health. The Fund is proud to highlight this important work in its first annual Impact Report:

Recently, US colleagues shared their personal “why” statements. At our Deerfield, Ill. office, we display these motivations along with a word cloud highlighting our collective focus. These reminders fuel our journey to advance brain health and transform lives.

RT @MATTERhealth: MATTER and @LundbeckUS Charitable Fund are proud to announce the Advancing Brain Health Challenge. Each participant will…

Lundbeck has officially completed the acquisition of Longboard Pharmaceuticals! This marks a transformative step in our journey to be a #FocusedInnovator and deepens our commitment to individuals affected by severe & rare epilepsies: #AdvancingBrainHealth

This #CaregiverAwarenessMonth, let’s take a moment to recognize the incredible efforts of care partners who support those living with migraine. Learn more about how you can support and care for someone living with migraine at @amfmigraine:

We are energized by the meaningful conversations and connections made with the #migraine community at #AHSAZ. Together we’re focused on elevating migraine care and evolving the treatment paradigm. #AdvancingBrainHealth #FocusedInnovator

In honor of #NationalFamilyCaregiversMonth, we teamed up with the Caregiver Action Network to raise awareness of the caregiver journey. Watch as Lundbeck's Judy Krieg shares her emotional experience being a caregiver to her mother with Alzheimer’s dementia: